pulmonologyadvisor1h
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
‘A Dangerous Virus’: Bird Flu Enters a New Phase
A pandemic is not inevitable, scientists say. But the outbreak has passed worrisome milestones in recent weeks, including ...
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
CNN on MSN12d
HHS invests nearly $600 million in Moderna’s bird flu vaccine development
In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and ... Moderna plans to advance ...
Hosted on MSN5d
Traws Pharma completes Phase I trials of H5N1 bird flu treatment drug
Traws Pharma has completed the Phase I clinical trials of tivoxavir marboxil, a single-dose drug for treating or preventing ...
FierceBiotech9d
HHS gives Moderna $590M to 'accelerate' bird flu vaccine trials
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
BioPharma Dive8d
Moderna gets $590M from US government for bird flu vaccine
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
Traws Pharma completes Phase I studies with tivoxavir marboxil
Traws Pharma (TRAW) announced completion of Phase I clinical studies of its investigational one-dose influenza therapy, tivoxavir marboxil, for ...
CNN12d
HHS invests nearly $600 million in Moderna’s bird flu vaccine development
In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect ... Moderna plans to advance research on the mRNA vaccine into a phase 3 trial after receiving positive results ...